GoodRx Holdings Inc has a consensus price target of $10.09 based on the ratings of 30 analysts. The high is $30 issued by Raymond James on March 2, 2022. The low is $4.5 issued by B of A Securities on January 2, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, RBC Capital, and Barclays on June 10, 2024, May 23, 2024, and May 20, 2024, respectively. With an average price target of $9.83 between Morgan Stanley, RBC Capital, and Barclays, there's an implied 11.11% upside for GoodRx Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/10/2024 | Buy Now | 7.34% | Morgan Stanley | Craig Hettenbach | $7 → $9.5 | Maintains | Equal-Weight | Get Alert |
05/23/2024 | Buy Now | 12.99% | RBC Capital | Mark Mahaney | $8 → $10 | Upgrade | Sector Perform → Outperform | Get Alert |
05/20/2024 | Buy Now | 12.99% | Barclays | Stephanie Davis | $9 → $10 | Maintains | Overweight | Get Alert |
05/16/2024 | Buy Now | 12.99% | Raymond James | John Ransom | → $10 | Upgrade | Market Perform → Outperform | Get Alert |
05/16/2024 | Buy Now | 80.79% | TD Cowen | Charles Rhyee | $14 → $16 | Maintains | Buy | Get Alert |
04/10/2024 | Buy Now | 1.69% | Keybanc | Scott Schoenhaus | → $9 | Upgrade | Sector Weight → Overweight | Get Alert |
03/25/2024 | Buy Now | 12.99% | Wells Fargo | Stan Berenshteyn | → $10 | Upgrade | Equal-Weight → Overweight | Get Alert |
03/08/2024 | Buy Now | -9.6% | RBC Capital | Sean Dodge | → $8 | Reiterates | Sector Perform → Sector Perform | Get Alert |
03/01/2024 | Buy Now | -15.25% | Wells Fargo | Stan Berenshteyn | $6 → $7.5 | Maintains | Equal-Weight | Get Alert |
03/01/2024 | Buy Now | -9.6% | UBS | Eric Sheridan | $5 → $8 | Maintains | Neutral | Get Alert |
03/01/2024 | Buy Now | -9.6% | RBC Capital | Sean Dodge | $7 → $8 | Maintains | Sector Perform | Get Alert |
03/01/2024 | Buy Now | -15.25% | Goldman Sachs | Eric Sheridan | $6.5 → $7.5 | Maintains | Neutral | Get Alert |
03/01/2024 | Buy Now | -9.6% | Truist Securities | Jailendra Singh | $7.5 → $8 | Maintains | Hold | Get Alert |
03/01/2024 | Buy Now | 58.19% | TD Cowen | Charles Rhyee | $12 → $14 | Maintains | Outperform | Get Alert |
03/01/2024 | Buy Now | 12.99% | JP Morgan | Lisa Gill | $7 → $10 | Upgrade | Neutral → Overweight | Get Alert |
03/01/2024 | Buy Now | 1.69% | Barclays | Steve Valiquette | $8 → $9 | Maintains | Overweight | Get Alert |
02/26/2024 | Buy Now | -9.6% | Leerink Partners | Michael Cherny | → $8 | Initiates | → Outperform | Get Alert |
01/16/2024 | Buy Now | -20.9% | RBC Capital | Sean Dodge | $5 → $7 | Maintains | Sector Perform | Get Alert |
01/12/2024 | Buy Now | -15.25% | Truist Securities | Jailendra Singh | $5.5 → $7.5 | Maintains | Hold | Get Alert |
01/02/2024 | Buy Now | -49.15% | B of A Securities | Michael Cherny | $8 → $4.5 | Downgrade | Buy → Underperform | Get Alert |
11/17/2023 | Buy Now | -32.2% | JP Morgan | Doug Anmuth | $7 → $6 | Maintains | Neutral | Get Alert |
11/13/2023 | Buy Now | -32.2% | Goldman Sachs | Eric Sheridan | $7 → $6 | Maintains | Neutral | Get Alert |
11/10/2023 | Buy Now | -43.5% | RBC Capital | Sean Dodge | $8 → $5 | Maintains | Sector Perform | Get Alert |
11/10/2023 | Buy Now | -32.2% | Goldman Sachs | Eric Sheridan | $7 → $6 | Maintains | Neutral | Get Alert |
11/10/2023 | Buy Now | -37.85% | Truist Securities | Jailendra Singh | $8 → $5.5 | Maintains | Hold | Get Alert |
11/10/2023 | Buy Now | -37.85% | Morgan Stanley | Ricky Goldwasser | $8 → $5.5 | Maintains | Equal-Weight | Get Alert |
09/14/2023 | Buy Now | -20.9% | JP Morgan | Doug Anmuth | $6 → $7 | Maintains | Neutral | Get Alert |
08/11/2023 | Buy Now | -20.9% | Goldman Sachs | Eric Sheridan | $6.25 → $7 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | -9.6% | Deutsche Bank | George Hill | $6 → $8 | Maintains | Hold | Get Alert |
08/10/2023 | Buy Now | 12.99% | Guggenheim | Sandy Draper | $8 → $10 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | -32.2% | JP Morgan | Doug Anmuth | $5 → $6 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | 24.29% | Citigroup | Daniel Grosslight | $7 → $11 | Maintains | Buy | Get Alert |
08/10/2023 | Buy Now | 12.99% | Evercore ISI Group | Mark Mahaney | $7 → $10 | Maintains | In-Line | Get Alert |
08/10/2023 | Buy Now | -20.9% | Goldman Sachs | Eric Sheridan | $6.25 → $7 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | -9.6% | Credit Suisse | Jonathan Yong | $7 → $8 | Maintains | Neutral | Get Alert |
08/10/2023 | Buy Now | -9.6% | RBC Capital | Sean Dodge | $6 → $8 | Maintains | Sector Perform | Get Alert |
08/10/2023 | Buy Now | 7.34% | DA Davidson | Robert Simmons | → $9.5 | Upgrade | Neutral → Buy | Get Alert |
08/10/2023 | Buy Now | -20.9% | Wells Fargo | Stan Berenshteyn | $6 → $7 | Maintains | Equal-Weight | Get Alert |
07/31/2023 | Buy Now | 35.59% | TD Cowen | Charles Rhyee | $6.5 → $12 | Upgrade | Market Perform → Outperform | Get Alert |
07/18/2023 | Buy Now | -20.9% | Truist Securities | Jailendra Singh | $6 → $7 | Maintains | Hold | Get Alert |
07/17/2023 | Buy Now | -9.6% | Morgan Stanley | Ricky Goldwasser | $6 → $8 | Maintains | Equal-Weight | Get Alert |
07/12/2023 | Buy Now | — | Keybanc | Scott Schoenhaus | — | Maintains | Sector Weight | Get Alert |
05/11/2023 | Buy Now | -9.6% | B of A Securities | Michael Cherny | $9 → $8 | Maintains | Buy | Get Alert |
05/11/2023 | Buy Now | -32.2% | RBC Capital | Sean Dodge | → $6 | Reiterates | Sector Perform → Sector Perform | Get Alert |
05/11/2023 | Buy Now | -29.38% | Goldman Sachs | Eric Sheridan | $7 → $6.25 | Maintains | Neutral | Get Alert |
05/11/2023 | Buy Now | -20.9% | Citigroup | Daniel Grosslight | $7.5 → $7 | Maintains | Buy | Get Alert |
03/08/2023 | Buy Now | -15.25% | Citigroup | Daniel Grosslight | $7 → $7.5 | Maintains | Buy | Get Alert |
03/07/2023 | Buy Now | -9.6% | Deutsche Bank | George Hill | $7 → $8 | Maintains | Hold | Get Alert |
03/02/2023 | Buy Now | -20.9% | Goldman Sachs | Eric Sheridan | $8 → $7 | Maintains | Neutral | Get Alert |
03/02/2023 | Buy Now | -9.6% | Credit Suisse | Jonathan Yong | $9 → $8 | Maintains | Neutral | Get Alert |
03/02/2023 | Buy Now | -32.2% | Wells Fargo | Stan Berenshteyn | $5.5 → $6 | Maintains | Equal-Weight | Get Alert |
03/01/2023 | Buy Now | -20.9% | Goldman Sachs | Eric Sheridan | $8 → $7 | Maintains | Neutral | Get Alert |
01/18/2023 | Buy Now | -9.6% | Barclays | Steve Valiquette | $9 → $8 | Maintains | Overweight | Get Alert |
12/01/2022 | Buy Now | -20.9% | Citigroup | Daniel Grosslight | → $7 | Initiates | → Buy | Get Alert |
11/09/2022 | Buy Now | -9.6% | Goldman Sachs | Eric Sheridan | $10 → $8 | Maintains | Neutral | Get Alert |
11/09/2022 | Buy Now | -32.2% | RBC Capital | Sean Dodge | $11 → $6 | Maintains | Sector Perform | Get Alert |
11/09/2022 | Buy Now | -32.2% | Morgan Stanley | Ricky Goldwasser | $10 → $6 | Maintains | Equal-Weight | Get Alert |
11/04/2022 | Buy Now | -9.6% | JP Morgan | Doug Anmuth | $10 → $8 | Upgrade | Underweight → Neutral | Get Alert |
10/11/2022 | Buy Now | 1.69% | Barclays | Ross Sandler | $13 → $9 | Maintains | Overweight | Get Alert |
09/16/2022 | Buy Now | — | Keybanc | Scott Schoenhaus | — | Initiates | → Sector Weight | Get Alert |
09/07/2022 | Buy Now | -26.55% | Truist Securities | Jailendra Singh | → $6.5 | Initiates | → Hold | Get Alert |
08/12/2022 | Buy Now | -9.6% | DA Davidson | Robert Simmons | → $8 | Initiates | → Neutral | Get Alert |
08/10/2022 | Buy Now | 12.99% | Morgan Stanley | Ricky Goldwasser | $10.5 → $10 | Maintains | Equal-Weight | Get Alert |
08/09/2022 | Buy Now | 24.29% | Credit Suisse | Jonathan Yong | $10 → $11 | Maintains | Neutral | Get Alert |
08/09/2022 | Buy Now | 12.99% | Goldman Sachs | Eric Sheridan | $9 → $10 | Maintains | Neutral | Get Alert |
08/09/2022 | Buy Now | 24.29% | RBC Capital | Sean Dodge | $6.5 → $11 | Maintains | Sector Perform | Get Alert |
08/09/2022 | Buy Now | 46.89% | Barclays | Steve Valiquette | $12 → $13 | Maintains | Overweight | Get Alert |
08/09/2022 | Buy Now | 24.29% | SVB Leerink | Stephanie Davis | $8 → $11 | Maintains | Market Perform | Get Alert |
07/20/2022 | Buy Now | 35.59% | Barclays | Steve Valiquette | $15 → $12 | Maintains | Overweight | Get Alert |
07/18/2022 | Buy Now | 46.89% | Guggenheim | Sandy Draper | $17 → $13 | Maintains | Buy | Get Alert |
06/23/2022 | Buy Now | -26.55% | RBC Capital | Sean Dodge | $8 → $6.5 | Maintains | Sector Perform | Get Alert |
06/22/2022 | Buy Now | -32.2% | Baird | Vikram Kesavabhotla | $7 → $6 | Maintains | Neutral | Get Alert |
06/13/2022 | Buy Now | 1.69% | Cowen & Co. | Charles Rhyee | $22 → $9 | Maintains | Market Perform | Get Alert |
06/10/2022 | Buy Now | 1.69% | Goldman Sachs | Eric Sheridan | $12 → $9 | Downgrade | Buy → Neutral | Get Alert |
06/06/2022 | Buy Now | 24.29% | B of A Securities | Michael Cherny | → $11 | Reinstates | → Buy | Get Alert |
06/01/2022 | Buy Now | -20.9% | Baird | Vikram Kesavabhotla | $10 → $7 | Downgrade | Outperform → Neutral | Get Alert |
05/20/2022 | Buy Now | 18.64% | Morgan Stanley | Ricky Goldwasser | $19 → $10.5 | Maintains | Equal-Weight | Get Alert |
05/12/2022 | Buy Now | 1.69% | Wells Fargo | Stan Berenshteyn | $20 → $9 | Maintains | Equal-Weight | Get Alert |
05/11/2022 | Buy Now | 35.59% | Goldman Sachs | Eric Sheridan | $30 → $12 | Maintains | Buy | Get Alert |
05/11/2022 | Buy Now | 12.99% | Deutsche Bank | George Hill | $20 → $10 | Maintains | Hold | Get Alert |
05/11/2022 | Buy Now | 12.99% | Credit Suisse | Jonathan Yong | $22 → $10 | Maintains | Neutral | Get Alert |
05/10/2022 | Buy Now | — | SVB Leerink | Stephanie Davis Demko | — | Downgrade | Outperform → Market Perform | Get Alert |
05/10/2022 | Buy Now | 69.49% | Barclays | Steve Valiquette | $28 → $15 | Maintains | Overweight | Get Alert |
05/10/2022 | Buy Now | 35.59% | Evercore ISI Group | Mark Mahaney | $28 → $12 | Downgrade | Outperform → In-Line | Get Alert |
05/10/2022 | Buy Now | — | Raymond James | John Ransom | — | Downgrade | Outperform → Market Perform | Get Alert |
05/10/2022 | Buy Now | -9.6% | RBC Capital | Sean Dodge | $35 → $8 | Downgrade | Outperform → Sector Perform | Get Alert |
04/11/2022 | Buy Now | 125.99% | Wells Fargo | Stan Berenshteyn | → $20 | Initiates | → Equal-Weight | Get Alert |
04/07/2022 | Buy Now | 171.19% | Guggenheim | Sandy Draper | → $24 | Initiates | → Buy | Get Alert |
03/17/2022 | Buy Now | 148.59% | Credit Suisse | Jailendra Singh | $27 → $22 | Maintains | Neutral | Get Alert |
03/15/2022 | Buy Now | 92.09% | Baird | Vikram Kesavabhotla | → $17 | Upgrade | Neutral → Outperform | Get Alert |
03/08/2022 | Buy Now | 216.38% | Barclays | Steve Valiquette | $35 → $28 | Maintains | Overweight | Get Alert |
03/02/2022 | Buy Now | 114.69% | Morgan Stanley | Ricky Goldwasser | $41 → $19 | Maintains | Equal-Weight | Get Alert |
03/02/2022 | Buy Now | 238.98% | Raymond James | Aaron Kessler | $45 → $30 | Maintains | Outperform | Get Alert |
03/02/2022 | Buy Now | 125.99% | Deutsche Bank | George Hill | $25 → $20 | Maintains | Hold | Get Alert |
03/01/2022 | Buy Now | 272.88% | SVB Leerink | Stephanie Davis | $49 → $33 | Maintains | Outperform | Get Alert |
03/01/2022 | Buy Now | 238.98% | Goldman Sachs | Eric Sheridan | $43 → $30 | Maintains | Buy | Get Alert |
03/01/2022 | Buy Now | 295.48% | RBC Capital | Sean Dodge | $50 → $35 | Maintains | Outperform | Get Alert |
03/01/2022 | Buy Now | 148.59% | Cowen & Co. | Charles Rhyee | $49 → $22 | Downgrade | Outperform → Market Perform | Get Alert |
03/01/2022 | Buy Now | 205.08% | Credit Suisse | Jailendra Singh | $41 → $27 | Downgrade | Outperform → Neutral | Get Alert |
01/07/2022 | Buy Now | 385.88% | Goldman Sachs | Eric Sheridan | → $43 | Initiates | → Buy | Get Alert |
The latest price target for GoodRx Holdings (NASDAQ:GDRX) was reported by Morgan Stanley on June 10, 2024. The analyst firm set a price target for $9.50 expecting GDRX to rise to within 12 months (a possible 7.34% upside). 39 analyst firms have reported ratings in the last year.
The latest analyst rating for GoodRx Holdings (NASDAQ:GDRX) was provided by Morgan Stanley, and GoodRx Holdings maintained their equal-weight rating.
The last upgrade for GoodRx Holdings Inc happened on May 23, 2024 when RBC Capital raised their price target to $10. RBC Capital previously had a sector perform for GoodRx Holdings Inc.
The last downgrade for GoodRx Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from $8 to $4.5 for GoodRx Holdings Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of GoodRx Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for GoodRx Holdings was filed on June 10, 2024 so you should expect the next rating to be made available sometime around June 10, 2025.
While ratings are subjective and will change, the latest GoodRx Holdings (GDRX) rating was a maintained with a price target of $7.00 to $9.50. The current price GoodRx Holdings (GDRX) is trading at is $8.85, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.